Who makes BRIDIN-plus Eye drops?

BRIDIN-plus Eye drops is developed by CHA University.

What development phase is BRIDIN-plus Eye drops in?

BRIDIN-plus Eye drops is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

BRIDIN-plus Eye drops

CHA University · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	BRIDIN-plus Eye drops
Also known as	Brimonidine tartrate 2.0mg, Timolol maleate 6.8mg(without preservative)
Sponsor	CHA University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BRIDIN-plus Eye drops CI brief — competitive landscape report
BRIDIN-plus Eye drops updates RSS · CI watch RSS
CHA University portfolio CI